Literature DB >> 6118197

Ultrastructural immunocytochemical localization of tyrosine hydroxylase in the neostriatum.

V M Pickel, S C Beckley, T H Joh, D J Reis.   

Abstract

The morphology and synaptic associations of dopaminergic axons in the n. caudate-putamen (neostriatum) of the adult rat brain are examined. Identification of dopaminergic axons is based upon the electron microscopic immunocytochemical localization of the catecholamine synthesizing enzyme, tyrosine hydroxylase. Immunoreactivity for the enzyme is detected in unmyelinated axons and axon terminals in serial sections collected throughout the neostriatum. The labeled terminals range from 0.1 to 1.5 micron in diameter and have peroxidase reaction product located around closely packed, round vesicles with a diameter of 40-60 nm. The tyrosine hydroxylase containing axon terminals constitute approximately 21% of the total number of terminals in the n. caudatus-putamen and include 3 types which differ in size and synaptic specializations. The most prevalent (82% of total), type I, is small (0.15-0.39 micron in diameter) and forms symmetric junctions with dendrites and dendritic spines. The other two terminal types (II and III) have a medium to large diameter (0.4-1.5 micron) and show either no membrane specializations or asymmetric junctions with dendrites. The axon terminals without observable membrane densities are occasionally oriented so as to suggest an association with dopaminergic and non-dopaminergic axon terminals. These findings indicate that while the dopaminergic terminals may form axoaxonic connections, the primary synaptic contacts are with dendrites of intrinsic neurons in all regions of n. caudatus-putamen.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6118197     DOI: 10.1016/0006-8993(81)90843-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  61 in total

1.  Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat Caudate putamen nucleus.

Authors:  J J Rodriguez; K Mackie; V M Pickel
Journal:  J Neurosci       Date:  2001-02-01       Impact factor: 6.167

2.  Caudate nucleus pathology in Parkinson's disease: ultrastructural and biochemical findings in biopsy material.

Authors:  B Lach; D Grimes; B Benoit; A Minkiewicz-Janda
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

3.  The effect of intrastriatal application of directly and indirectly acting dopamine agonists and antagonists on the in vivo release of acetylcholine measured by brain microdialysis. The importance of the post-surgery interval.

Authors:  P De Boer; G Damsma; Q Schram; J C Stoof; J Zaagsma; B H Westerink
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-02       Impact factor: 3.000

4.  Enhanced dendritic availability of μ-opioid receptors in inhibitory neurons of the extended amygdala in mice deficient in the corticotropin-releasing factor-1 receptor.

Authors:  Azra Jaferi; Ping Zhou; Virginia M Pickel
Journal:  Synapse       Date:  2011-01       Impact factor: 2.562

Review 5.  The bowel and beyond: the enteric nervous system in neurological disorders.

Authors:  Meenakshi Rao; Michael D Gershon
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-07-20       Impact factor: 46.802

Review 6.  Presynaptic nicotinic receptors: a dynamic and diverse cholinergic filter of striatal dopamine neurotransmission.

Authors:  R Exley; S J Cragg
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

7.  Single Synaptic Observation of Cholinergic Neurotransmission on Living Neurons: Concentration and Dynamics.

Authors:  Mei Shen; Zizheng Qu; Justin DesLaurier; Theresa M Welle; Jonathan V Sweedler; Ran Chen
Journal:  J Am Chem Soc       Date:  2018-06-15       Impact factor: 15.419

8.  Co-treatment with rivastigmine and idalopirdine reduces the propensity for falls in a rat model of falls in Parkinson's disease.

Authors:  Ajeesh Koshy Cherian; Aaron Kucinski; Ryan Wu; Inge E M de Jong; Martin Sarter
Journal:  Psychopharmacology (Berl)       Date:  2019-01-04       Impact factor: 4.530

9.  Different loss of dopamine transporter according to subtype of multiple system atrophy.

Authors:  Hae Won Kim; Jae Seung Kim; Minyoung Oh; Jungsu S Oh; Sang Joo Lee; Seung Jun Oh; Sun Ju Chung; Chong Sik Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-09-19       Impact factor: 9.236

Review 10.  Where attention falls: Increased risk of falls from the converging impact of cortical cholinergic and midbrain dopamine loss on striatal function.

Authors:  Martin Sarter; Roger L Albin; Aaron Kucinski; Cindy Lustig
Journal:  Exp Neurol       Date:  2014-05-05       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.